Serial proton magnetic resonance spectroscopy of the brain in children undergoing cardiac surgery

被引:14
|
作者
Ashwal, S
Holshouser, BA
del Rio, MJ
Tong, KA
Applegate, RL
Bailey, LL
机构
[1] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Sch Med, Dept Radiol, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Sch Med, Dept Surg, Loma Linda, CA 92350 USA
[4] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92350 USA
关键词
D O I
10.1016/S0887-8994(03)00045-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We used proton magnetic resonance spectroscopy to study 11 children (age < 8 years) with congenital heart disease undergoing cardiopulmonary bypass to determine whether low (10 +/- 4; n = 6) vs high (20 +/- 4; n = 5) perfusate hematocrits during bypass resulted in changes in brain metabolites which correlate with neurologic injury. Long and short echo time single voxel magnetic resonance spectroscopy in occipital gray matter and neurologic assessment were performed preoperatively and 2 and 5 days postoperatively. We also determined whether prolonged periods at low flow rates during bypass affected spectroscopy variables. We found no significant differences in metabolite ratios between the low vs high hematocrit groups or the lower vs higher flow rate groups (repeated measures analysis of variance of observation ranks converted to normal scores). However, our study was limited by statistical power due to the small sample size, therefore no conclusions could be made. Additional studies involving a greater number of patients are necessary. In all 11 children, magnetic resonance spectroscopy detected a significant decrease in brain N-acetyl-aspartate, and increases in myoinositol and glutamate/glutamine after surgery (Quade test) demonstrating that magnetic resonance spectroscopy is sensitive in detecting subtle postoperative changes in brain metabolites. (C) 2003 by Elsevier Inc. All rights reserved.
引用
收藏
页码:99 / 110
页数:12
相关论文
共 50 条
  • [31] Proton Magnetic Resonance Spectroscopy in Differential Diagnosis of Brain Tumors
    Lobanov, I. A.
    Shakhov, B. E.
    Medyanik, I. A.
    Fraerman, A. P.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2013, 5 (02) : 72 - 76
  • [32] Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria
    Möller, HE
    Wegelage, J
    Bick, U
    Wiedermann, D
    Feldmann, R
    Ullrich, K
    PEDIATRICS, 2003, 112 (06) : 1580 - 1583
  • [33] Brain proton magnetic resonance spectroscopy in Alzheimer's disease
    Xie, HG
    Cheng, LQ
    Wang, LM
    Cai, YQ
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S482 - S482
  • [34] Proton magnetic resonance spectroscopy in brain tumours:: clinical applications
    Burtscher, IM
    Holtås, S
    NEURORADIOLOGY, 2001, 43 (05) : 345 - 352
  • [35] Brain macromolecules: In vivo measurement by proton magnetic resonance spectroscopy
    Graham, GD
    NEUROSCIENTIST, 1996, 2 (06): : 309 - 312
  • [36] Proton magnetic resonance spectroscopy of brain tumors correlated with pathology
    Magalhaes, A
    Godfrey, W
    Shen, YM
    Hu, JN
    Smith, W
    ACADEMIC RADIOLOGY, 2005, 12 (01) : 51 - 57
  • [37] Proton magnetic resonance spectroscopy in brain tumours: clinical applications
    I. M. Burtscher
    S. Holtås
    Neuroradiology, 2001, 43 : 345 - 352
  • [38] Magnetic resonance proton spectroscopy of the brain in Wilson’s disease
    E. Kraft
    Claudia Trenkwalder
    Florian Then Bergh
    Dorothee P. Auer
    Journal of Neurology, 1999, 246 : 693 - 699
  • [39] Proton magnetic resonance spectroscopy in brain white matter disorders
    De Stefano, N
    Federico, A
    Arnold, DL
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1997, 18 (06): : 331 - 339
  • [40] Analysis of brain tumours using proton magnetic resonance spectroscopy
    Asakura, T
    Hirakawa, W
    CRITICAL REVIEWS IN NEUROSURGERY, 1997, 7 (04) : 252 - 257